Cargando...
Immunomodulatory action of SGI-110, a hypomethylating agent, in acute myeloid leukemia cells
The mechanism of clinical action for the FDA approved hypomethylating drugs azacitidine and decitabine remains unresolved and in this context the potential immunomodulatory effect of these agents on leukemic cells is an area of active investigation. Induced expression of methylated Cancer Testis Ant...
Gardado en:
| Publicado en: | Leuk Res |
|---|---|
| Main Authors: | , , , , , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado: |
2014
|
| Assuntos: | |
| Acceso en liña: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5584559/ https://ncbi.nlm.nih.gov/pubmed/25260825 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.leukres.2014.09.001 |
| Tags: |
Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!
|